Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis (IMAGE)

Xia & He Publishing Inc.

Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis

Caption

The combination of plasma levels of NfL, GFAP, tau, and UCHL1 exhibits competent performance in diagnosing MHE, and MELD score, IL-6, and GFAP, rather than plasma NfL, tau, and UCHL1 levels, appear to be the predictors of 30-day OHE development in patients with hepatic cirrhosis.

Credit

Tao Chen, Qin Ning, Qiuyu Cheng

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.